Systemic administration of adenosine ameliorates pentylenetetrazol-induced chemical kindling and secondary behavioural and biochemical changes in mice

Fundamental and Clinical Pharmacology

Volumn 21, Issue 6, 2007, Pages 583-594

  Akula, Kiran Kumar ^a   Dhir, Ashish ^a   Kulkarni, S K ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

Adenosine; Convulsions; Kindling; Oxidative stress; Pentylenetetrazol

Indexed keywords

ADENOSINE; ADENOSINE DEAMINASE; ANTICONVULSIVE AGENT; ASCORBIC ACID; CATALASE; GLUTATHIONE; MALONALDEHYDE; NITRITE; PENTETRAZOLE; RNA;

AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; BEHAVIOR CHANGE; BEHAVIORAL SCIENCE; BIOCHEMISTRY; BRAIN HOMOGENATE; CHEMICAL ANALYSIS; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DRUG RESPONSE; HYPERALGESIA; KINDLING; LIPID PEROXIDATION; LOCOMOTION; MALE; MOUSE; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; RATING SCALE; SCORING SYSTEM; SEIZURE;

ADENOSINE; ADENOSINE DEAMINASE; ANIMALS; ANTICONVULSANTS; BEHAVIOR, ANIMAL; HYPERALGESIA; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; KINDLING, NEUROLOGIC; LIPID PEROXIDATION; MALE; MEMORY; MICE; MOTOR ACTIVITY; PENTYLENETETRAZOLE; PITUITARY-ADRENAL SYSTEM;

EID: 36349008621     PISSN: 07673981     EISSN: 14728206     Source Type: Journal    
DOI: 10.1111/j.1472-8206.2007.00540.x     Document Type: Article

References (56)

1. Boison D. Adenosine and epilepsy: from therapeutic rationale to new therapeutic strategies. Neuroscientist (2005) 11 25 36.
2. Ribeiro J.A. Purinergic regulation of transmitter release, in : Phillis J.W. (Ed. Adenosine and adenine nucleotides as regulators of cellular function, CRC Press, Boca Raton, FL, 1991, pp. 155.
3. Pagonopoulou O., Efthimiadou A., Asimakopoulos B., Nikolettos N.K. Modulatory role of adenosine and its receptors in epilepsy: possible therapeutic approaches. Neurosci. Res. (2006) 56 14 20.
4. Windscheif U. Purinoceptors: from history to recent progress. A review. J. Pharm. Pharmacol. (1996) 48 993 1011.
5. Fedele D.E., Li T., Lan J.Q., Fredholm B.B., Boison D. Adenosine A1 receptors are crucial in keeping an epileptic focus localized. Exp. Neurol. (2006) 200 184 190.
6. Patel M.N. Oxidative stress, mitochondrial dysfunction, and epilepsy. Free Radic. Res. (2002) 36 1139 1146.
7. Dhir A., Naidu P.S., Kulkarni S.K. Effect of naproxen, a non-selective cyclo-oxygenase inhibitor, on pentylenetetrazol-induced kindling in mice. Clin. Exp. Pharmacol. Physiol. (2005) 32 579 584.
8. Morimoto K. Seizure-triggering mechanisms in the kindling model of epilepsy: Collapse of GABA-mediated inhibition and activation of NMDA receptors. Neurosci. Biobehav. Rev. (1989) 13 253 260.
9. Adamec R.E. Amygdala kindling and anxiety in the rat. Neuroreport (1990) 1 255 258.
10. Genkova-Papazova M.G., Lazarova-Bakarova M.B. Piracetam and fipexide prevent PTZ-kindling-provoked amnesia in rats. Eur. Neuropsychopharmacol. (1996) 6 285 290.
11. Ilhan A., Iraz M., Kamisli S., Yigitoglu R. Pentylenetetrazol-induced kindling seizure attenuated by Ginkgo biloba extract (EGb 761) in mice. Prog. Neuropsychopharmacol. Biol. Psychiatry (2006) 30 1504 1510.
12. Dhir A., Padi S.S., Naidu P.S., Kulkarni S.K. Protective effect of naproxen (non-selective COX-inhibitor) or rofecoxib (selective COX-2 inhibitor) on immobilization stress-induced behavioral and biochemical alterations in mice. Eur. J. Pharmacol. (2006) 535 192 198.
13. Stone T.W. Adenosine, neurodegeneration and neuroprotection. Neurol. Res. (2005) 27 161 168.
14. Malhotra J., Gupta Y.K. Effect of adenosine receptor modulation on pentylenetetrazole-induced seizures in rats. Br. J. Pharmacol. (1997) 120 282 288.
15. Bruno A.N., Fontella F.U., Bonan C.D., Barreto-Chaves M.L., Dalmaz C., Sarkis J.J. Activation of adenosine A(1) receptors alters behavioral and biochemical parameters in hyperthyroid rats. Behav. Brain Res. (2005) 167 287 294.
16. Listos J., Malec D., Fidecka S. Influence of adenosine receptor agonists on benzodiazepine withdrawal signs in mice. Eur. J. Pharmacol. (2005) 523 71 78.
17. Singh A., Kulkarni S.K. Role of adenosine in drug-induced catatonia in mice. Indian J. Exp. Biol. (2002) 40 882 888.
18. George B., Kulkarni S.K. Modulation of lithium-pilocarpine-induced status epilepticus by adenosinergic agents. Methods Find. Exp. Clin. Pharmacol. (1997) 19 329 333.
19. Mehta A.K., Kulkarni S.K. Effect of purinergic substances on rectal temperature in mice: involvement of P1-purinoceptors. Arch. Int. Pharmacodyn. Ther. (1983) 264 180 186.
20. Prediger R.D., Takahashi R.N. Modulation of short-term social memory in rats by adenosine A1 and A(2A) receptors. Neurosci. Lett. (2005) 376 (3) 160 165.
21. Itoh J., Nabeshima T., Kameyania T. Utility of an elevated plus-maze for dissociation of amnesic and behavioral effects of drugs in mice. Eur. J. Pharmacol. (1991) 194 71 74.
22. Sharma A.C., Kulkarni S.K. Evaluation of learning and memory mechanisms employing elevated plus-maze in rats and mice. Prog. Neuropsychopharmacol. Biol. Psychiatry. (1992) 16 117 125.
23. Kulkarni S.K., Reddy D.S. Animal behavioral models for testing antianxiety agents. Methods Find. Exp. Clin. Pharmacol. (1996) 18 219 230.
24. Wills E.D. Mechanism of lipid peroxide formation in animal tissues. Biochem. J. (1966) 99 667 676.
25. Ellman G.L. Tissue sulfhydryl groups. Arch. Biochem. Biophys. (1959) 82 70 77.
26. Raghvendra V., Agrewal J.N., Kulkarni S.K. Melatonin reversal of lipopolysaccharide-induced thermal and behavioral hyperalgesia in mice. Eur. J. Pharmacol. (2000) 395 15 21.
27. Luck H. Catalase spectrophotometric method. Methods in enzymatic analysis. Academic Press, New York, 1963.
28. Roe J.H., Kuether C.A. The determination of ascorbic acid in whole blood and urine through the 2, 4-dinitrophenyl hydrazine derivative of dehydro ascorbic acid. J. Biol. Chem. (1943) 147 399 407.
29. Giusti G. Adenosine deaminase, in : Bergmeyer M.V. (Ed.) Methods of enzymatic analysis, 2nd edn, Academic Press, New York, 1974, pp. 1092 1098.
30. Monro H.N., Fleck A. The determination of nucleic acids, in : Glick D. (Ed.) Methods in biochemical analysis, Vol.14, Wiley, New York, 1966, pp. 114 176.
31. Reddy D.S., Kulkarni S.K. Role of GABA-A and mitochondrial diazepam binding inhibitor receptors in the anti-stress activity of neurosteroids in mice. Psychopharmacology (Berl) (1996) 128 280 292.
32. Lowry O.H., Rosenberg N.J., Farr A.L., Randall R.J. Protein measurement with the Folin-phenol reagent. J. Biol. Chem. (1951) 193 265 275.
33. Phillis J.W., Wu P.H. The role of adenosine and its metabolites in central synaptic transmission. Prog. Neurobiol. (1981) 16 187 239.
34. Bortolott Z.A., Mello L.E., Turski L., Cavalheiro E.A. Effect of 2-chloroadenosine on amygdaloid and hippocampal kindled seizures. Arch. Int. Pharmacodyn. Ther. (1985) 277 313 320.
35. Dragunow M., Goddard G.V., Laverty R. Is adenosine an endogenous anticonvulsant? Epilepsia (1985) 26 480 487.
36. Mason C.R., Cooper R.M. A permanent change in convulsive threshold in normal and brain-damaged rats with repeated small doses of pentylenetetrazol. Epilepsia (1972) 13 663 674.
37. Corda M.G., Orlandi M., Lecca D., Carboni G., Frau V., Giorgi O. Decrease in the function of g-aminobutyric acid-coupled chloride channel produced by the repeated administration of pentylenetetrazol to rats. J. Neurochem. (1990) 55 1216 1221.
38. Cunha R.A. Adenosine as a neuromodulator and as a homeostatic regulator in the nervous system: different roles, different sources and different receptors. Neurochem. Int. (2001) 38 107 125.
39. Dragunow M., Goddard G.V. Adenosine modulation of amygdale kindling. Exp. Neurobiol. (1984) 84 654 665.
40. Angelatou F., Pagonopoulou O., Kostopoulos G. Alterations of A1 adenosine receptors in different mouse brain areas after pentylenetetrazol-induced seizures, but not in the epileptic mutant mouse 'tottering'. Brain. Res. (1990) 534 251 256.
41. Pagonopoulou O., Angelatou F., Kostopoulos G. Effect of pentylentetrazol-induced seizures on A1 adenosine receptor regional density in the mouse brain: a quantitative autoradiographic study. Neuroscience (1993) 56 711 716.
42. Parihar M.S., Pandit M.K. Free Radical Induced Increase in Protein Carbonyl is attenuated by Low Dose of Adenosine in Hippocampus and Mid Brain: Implication in Neurodegenerative Disorders. Gen. Physiol. Biophys. (2003) 22 29 39.
43. Goddard G.V., Douglas R.M. Does the engram of kindling model the engram of normal long-term memory? in : Wada J (Ed), Kindling, Can. J. Neurol. Sci., 1975, 2, 385 394.
44. da Silva Torres I.L., Bonan C.D., Crema L., De Leon Nunes M., Battastini A.M., Sarkis J.J., Dalmaz C., Ferreira M.B. Effect of drugs active at adenosine receptors upon chronic stress-induced hyperalgesia in rats. Eur. J. Pharmacol. (2003) 481 197 201.
45. Sawynok J. Adenosine and ATP receptors. Handb. Exp. Pharmacol. (2007) 177 309 328.
46. Coyle J.T. Oxidative stress, glutamate, neurodegeneration disorders. Science (1993) 262 689 695.
47. Haliwell B. Reactive oxygen species and the central nervous system. J. Neurochem. (1992) 59 1609 1623.
48. Singh A, Kumar G., Naidu P.S., Kulkarni S.K. Protective effect of FK-506 (tacrolimus) in pentyle.netetrazol-induced kindling in mice. Pharmacol. Biochem. Behav. (2003) 75 853 860.
49. Weiss G.K., Castillo N., Fernandez M. Amygdala kindling rate is altered in rats with a deficit in the responsiveness of the hypothalamo-pituitary- adrenal axis. Neurosci. Lett. (1993) 57 91 94.
50. Weiss G., Lucero K., Fernandez M., Karnaze D., Castillo N. The effect of adrenalectomy on the circadian variation in the rate of kindled seizure development. Brain. Res. (1993) 612 354 356.
51. Kipp D.E., Rivers J.M. Uptake and release of adrenal ascorbic acid in the guinea pig after injection of ACTH. J. Nutr. (1987) 117 1570 1575.
52. Ross F.M., Brodie M.J., Stone T.W. Modulation by adenine nucleotides of epileptiform activity in the CA3 region of rat hippocampal slices. Br. J. Pharmacol. (1998) 123 71 80.
53. Southam E., Stratton S.C., Sargent R.S., Brackenborough K.T., Duffy C., Hagan R.M., Pratt G.D., Jones S.A., Morgan P.F. Broad spectrum anticonvulsant activity of BW534U87: possible role of an adenosine-dependent mechanism. Pharmacol. Biochem. Behav. (2002) 74 111 118.
54. Kikuchi S., Iwasa H., Sato T. Lasting changes in NMDAR1 mRNA level in various regions of cerebral cortex in epileptogenesis of amygdaloid-kindled rat. Psychiatry Clin. Neurosci. (2000) 54 573 577.
55. Nishimura T., Schwarzer C., Gasser E., Kato N., Vezzani A., Sperk G. Altered expression of GABA(A) and GABA(B) receptor subunit mRNAs in the hippocampus after kindling and electrically induced status epilepticus. Neuroscience (2005) 134 691 704.
56. Gawlowicz M., Reichert M., Wojcierowski J., Czuczwar S.J., Borowicz K.K. Apoptotic markers in various stages of amygdala kindled seizures in rats. Pharmacol. Rep. (2006) 58 512 518.